Vaccine
Bangladesh seeks UK support for vaccine centre
Health Minister Dr Samanta Lal Sen has sought support from the Oxford Vaccine Group at the University of Oxford to establish a vaccine centre in Bangladesh.
Covid-19 vaccination campaign to restart: DGHS
The government has decided to restart distribution and administration of Covid-19 vaccines amid recent rise in infection across the country
From Covid to cancer: High hopes for Nobel mRNA vaccines
The coronavirus pandemic brought global renown to the mRNA technology that underpins vaccines from Pfizer/BioNTech and Moderna, and on Monday earned a Nobel Prize for two scientists who have been key to its development
US government to urge Americans to get new Covid-19 boosters
The Biden administration plans to urge all Americans to get a booster shot for the coronavirus this autumn to counter a new wave of infections, a White House official said on Sunday
World's first intranasal Covid vaccine launched in Delhi
The world's first intranasal Covid-19 vaccine was launched in India's New Delhi today.
Fourth Covid-19 shot campaign begins
A special campaign for administering the fourth Covid-19 vaccine dose starts today.
Administration of 4th Covid dose to start Dec 20
A special campaign for administering fourth Covid vaccine dose will start on December 20.
Administration of 4th Covid jab to start Dec 20
Administration of the fourth dose of Covid vaccine will begin on December 20 at seven vaccination centres in Dhaka.
Omicron-specific booster may not be needed: US study
A study in monkeys pitting the current Moderna Inc Covid-19 booster against an Omicron-specific booster showed no significant differences in protection, suggesting an Omicron-specific booster may not be needed, US government researchers reported on Friday.
European Investment Bank to provide €250m for Covid-19 immunisation
European Investment Bank (EIB), the bank of the European Union and the largest multilateral lender in the world, will provide €250 million to Bangladesh to support procurement of safe and effective vaccines and country-wide immunisation against Covid-19.
Pfizer asks US to authorise Covid vaccine for children under 5
Pfizer on Tuesday asked the US to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March.
Moderna gets full US FDA approval for its Covid-19 vaccine
US health regulators on Monday granted full approval to Moderna’s COVID-19 vaccine, a shot that’s already been given to tens of millions of Americans since its emergency authorization over a year ago.
US provides 10m more doses of Pfizer vaccine to Bangladesh
The US has donated an additional 10 million doses of Pfizer’s Covid-19 vaccine to Bangladesh via COVAX, bringing the total US contribution to more than 38.6 million doses -- with millions more scheduled to arrive over the coming months.
India says 75% of its adult population fully vaccinated against Covid
India says it has fully vaccinated 75 percent of its estimated 94 crore adult population with Covid-19 vaccines.
Covid booster dose for all above 40: Health Minister
The government has again lowered the age limit -- to 40 -- for booster dose of Covid-19 vaccine.
Covid-19: Bharat Biotech gets approval for phase-3 trial of intranasal booster dose
The Drugs Controller General of India today permitted its domestic pharma major Bharat Biotech for conducting human trials of its intranasal Covid-19 booster dose for those who have already been inoculated with two doses of the Covaxin injection.
Covid-19 Omicron shots: Pfizer begins testing in adults
Pfizer is enrolling healthy adults to test a reformulated COVID-19 vaccine that matches the hugely contagious omicron variant, to see how it compares with the original shots.
Bangladesh receives 2.12m AstraZeneca doses from France
France has donated another 2.12 million doses of AstraZeneca vaccine to Bangladesh through the global sharing platform -- COVAX -- as a gesture of solidarity to its people in their fight against Covid-19 pandemic.